Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Clare Kahn currently holds 30,782 shares of Solid Biosciences Inc. (SLDB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Clare Kahn has been a net buyer of SLDB stock. They have purchased $8.4K and sold $0 worth of shares.
Clare Kahn's most recent insider trade was on Apr 3, 2026, when they sold 30,782 shares at $0.00 per share.
Clare Kahn serves as Executive at Solid Biosciences Inc. (SLDB). They have executed 3 insider transactions totaling $8.4K over their tenure at the company.
Clare Kahn holds the position of Executive at Solid Biosciences Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Clare Kahn has shown a buying trading pattern, with $8.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Clare Kahn was on Jun 7, 2024, when they purchased $8.4K worth of SLDB shares. This transaction involved 1,100 shares at $7.67 per share.
Clare Kahn currently owns 30,782 shares of Solid Biosciences Inc. (SLDB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Clare Kahn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Clare Kahn has 3 Form 4 filings on record as an insider at Solid Biosciences Inc..
Set alerts for Clare Kahn and 40,000+ other insiders.